Welcome to ALTG

Australia Day Awards

These awards recognise the valuable contribution they have made to their respective fields. Professor David Ball AO for distinguished services to medicine in the field of radiation oncology, medical education and to professional bodies, Professor Matthew Peters AM for significant service to thoracic medicine, medical education and to professional organisations, and Ms. Sue McCollough OAM for services to community health. Congratulations on richly deserved awards .


ALTG Study, ILLUMINATE Study (ALTG 16/009) is now open to recruitment. This is a phase 2 trial of durvalumab and tremelimumab with chemotherapy in metastatic EGFR mutant non-squamous non-small cell lung cancer (NSCLC) following progression on epidermal growth factor receptor (EGFR) mutation Tyrosine Kinase Inhibitors (TKIs).

For Patients

Upcoming Events

Upcoming Events
  1. 5th ALTG Preceptorship in Lung Cancer

    October 18 @ 10:00 am - October 19 @ 4:00 pm